FACTOR VIII B CELL EPITOPE VARIANTS HAVING REDUCED IMMUNOGENICITY

摘要

Provided herein are methods and compositions for preventing or reducing an initial immune response to factor VIII in patients suffering from hemophilia A and for reducing the intensity of the immune response in patients having pre-formed inhibitor antibodies against factor VIII.